BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21541295)

  • 1. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
    Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
    PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
    Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W
    Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.
    Mai J; Huang Y; Mu C; Zhang G; Xu R; Guo X; Xia X; Volk DE; Lokesh GL; Thiviyanathan V; Gorenstein DG; Liu X; Ferrari M; Shen H
    J Control Release; 2014 Aug; 187():22-9. PubMed ID: 24818768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD24 controls Src/STAT3 activity in human tumors.
    Bretz NP; Salnikov AV; Perne C; Keller S; Wang X; Mierke CT; Fogel M; Erbe-Hofmann N; Schlange T; Moldenhauer G; Altevogt P
    Cell Mol Life Sci; 2012 Nov; 69(22):3863-79. PubMed ID: 22760497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
    Wang J; Xu J; Xing G
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells.
    Jaganathan S; Yue P; Paladino DC; Bogdanovic J; Huo Q; Turkson J
    PLoS One; 2011 May; 6(5):e19605. PubMed ID: 21573184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
    Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
    Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
    BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P; Srivastava SK
    BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
    Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
    Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
    Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
    Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
    Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
    Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
    Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
    Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop.
    Aceto N; Sausgruber N; Brinkhaus H; Gaidatzis D; Martiny-Baron G; Mazzarol G; Confalonieri S; Quarto M; Hu G; Balwierz PJ; Pachkov M; Elledge SJ; van Nimwegen E; Stadler MB; Bentires-Alj M
    Nat Med; 2012 Mar; 18(4):529-37. PubMed ID: 22388088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.